Methods for diagnosing and treating neuroendocrine cancer

The present invention relates to a method for diagnosing neuroendocrine cancers via detecting the presence of N-methyl D-asparate-associated (NMDA) glutamate receptors type 1 and/or type 2. Methods for preventing and treating neuroendocrine cancers are also disclosed.

US 20,110,086,022

Inventor(s): NORTH WILLIAM G [US]

Type of Offer: Licensing

Next Patent »
« More Medical Patents
« More Diagnostic Patents

Share on      

CrowdSell Your Patent